We are live on ! Find out more
MTACU

MedTech Acquisition Corporation Unit
MTACU

Delisted

MTACU was delisted on the 10th of August, 2023.

Back to rankings

3 hedge funds and large institutions have $2.02K invested in MedTech Acquisition Corporation Unit in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 4 → 3 (-1)

75% less capital invested

Capital invested by funds: $8.06K → $2.02K (-$6.04K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$6.04K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
1
Tower Research Capital (TRC)
New York
$2K – – –
DM
2
Deerfield Management
New York
$10 – – –
Wells Fargo
3
Wells Fargo
California
$10 – – –
UBS Group
4
UBS Group
Switzerland
– -$6.04K -606 Closed

MTACU Hedge Fund Activity: Q1 2023 in Review

3 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q1 2023, worth a combined $2.02K — down 75% from $8.06K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of MTACU and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was UBS Group, exiting entirely with an estimated $6.04K sold.

  • 3 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q1 2023, down from 4 in Q4 2022.
  • Funds reported $2.02K of MedTech Acquisition Corporation Unit stock for Q1 2023, down 75% quarter-over-quarter.
  • 0 funds opened new MedTech Acquisition Corporation Unit positions in Q1 2023 and 1 closed out, a net change of -1 holder.
  • The largest MedTech Acquisition Corporation Unit seller in Q1 2023 was UBS Group, an estimated $6.04K sold.

Based on aggregated 13F filings for Q1 2023.